Add to favorites:
Share:
This call aims to continue the development of the European Research Area (ERA) for health research under Horizon Europe. The focus is on supporting activities that enable or contribute to reducing disease burdens across Europe. Through effective governance and collaboration, the initiative prioritizes topics such as cardiovascular diseases, public health, nanomedicine, and clinical trials for investigator-initiated studies. This partnership leverages multi-country collaboration to provide robust clinical evidence for improving health interventions, enhancing the sustainability and equity of healthcare systems, and promoting personalized medicine and public health strategies. The action builds on Phase 1 achievements, emphasizing transnational calls, funding mechanisms, and the integration of additional partners.
Opening: 13-05-2025
Deadline(s): 03-06-2025
Data provided by Kooperationsstelle Wissenschaft
This funding opportunity represents a pre-agreed draft that has not yet been officially approved by the European Commission. The final, approved version is expected to be published in the first quarter of 2025. This draft is provided for informational purposes and may be used to preliminarily form consortia and develop project ideas, but it is offered without any guarantees or warranties.
Expected Outcome
• Establish effective governance and research collaboration frameworks
• Support large-scale multi-country Investigator-Initiated Clinical Studies (IICSs)
• Generate robust clinical evidence to optimize patient care and public health policies
• Improve knowledge sharing to enhance healthcare system efficiency and integration
• Strengthen public engagement in health decisions and improve adherence to strategies
Scope
• Strengthen transnational collaboration in health research funding
• Support non-commercial clinical studies for multi-country trials
• Prioritize diseases such as cardiovascular issues, public health, and nanomedicine
• Foster integration and knowledge sharing among research funders and policymakers
• Enhance public health systems’ sustainability and resilience